Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction
Authors:
- Stephan G. NekollaStephan G. Nekolla
- Mira HörnkeMHMira Hörnke
- Hubertus P. BülowHBHubertus P. Bülow
- Josef DirschingerJDJosef Dirschinger
- Albert SchömigASAlbert Schömig
- Markus SchwaigerMarkus Schwaiger
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Assessment of Myocardial Viability With Contrast-Enhanced Magnetic Resonance ImagingCirculation, 2002
- Imaging Time After Gd-DTPA Injection Is Critical in Using Delayed Enhancement to Determine Infarct Size Accurately With Magnetic Resonance ImagingCirculation, 2001
- Contrast-enhanced magnetic resonance imaging of myocardium at riskJACC, 2000
- Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 2000
- Assessing the Myocardium After Attempted ReperfusionCirculation, 1998
- Assessment of Myocardial Viability With 99m Tc Sestamibi in Patients Undergoing Cardiac TransplantationCirculation, 1996
- Regional Heterogeneity of Human Myocardial Infarcts Demonstrated by Contrast-Enhanced MRICirculation, 1995
- Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable?Circulation, 1993
- Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: Identification of the myocardial bed at riskJACC, 1988
- Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile.Circulation, 1988